GlassVC
Matthew Hammond

Matthew Hammond

Partner · RA Capital Management

PartnerBoston, MA

Matthew Hammond is a Partner at RA Capital working across public and private investments, and serves as a board director for Ambros Therapeutics. He previously served as a director of DTx Pharma, Emergence Therapeutics, Forge Biologics and Jnana Therapeutics, each until its acquisition. He holds a Ph.D. in biomedical science and an MBA from the University of Connecticut.

Board seats

51 current

· PUBLIC SOURCES

Credited hits

4

· PUBLIC SOURCES

Midas years

No public record

LAST CHECKED NOV 2026

Founder rating

No public record

LAST CHECKED NOV 2026

Maintained from public sources. Not claimed. If you're Matthew Hammond, you can claim this profile.

Claim this profileHow claiming works

Claiming verifies identity and affiliation. It does not permit editing reviews, scores, or cited facts.

Track record

Credited deals only — Matthew Hammond is named in a public source as investor, lead, or board member on these deals. This is not a complete investment history, and absence here is not evidence of absence.
  • DTx Pharmaacquired

    Acquired by Novartis; Hammond served as a director prior to the acquisition, per RA Capital team page.

    Source: ra-capital-prod.azurewebsites.net

  • Emergence Therapeuticsacquired

    Acquired by Eli Lilly; Hammond served as a director prior to the acquisition, per RA Capital team page.

    Source: ra-capital-prod.azurewebsites.net

  • Forge Biologicsacquired

    Acquired by Ajinomoto; Hammond served as a director prior to the acquisition, per RA Capital team page.

    Source: ra-capital-prod.azurewebsites.net

  • Jnana Therapeuticsacquired

    Acquired by Otsuka; Hammond served as a director prior to the acquisition, per RA Capital team page.

    Source: ra-capital-prod.azurewebsites.net

Board seats

Current board seats · 1

Former board seats · 4

Success signals

Forbes Midas List

No public record

Not listed.

Reputation

No reputation score — basis not established for this investor.

No reputation sources on file yet.

Suggest a source

Contact

Published sources only

Published contact details collected from public sources. Not a referral, and not an introduction.

Published contact

Published sources only

GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.

Claimed profiles can replace or remove contact details.

What founders say

Founder-submitted · Verified identity and relationship

No founder reviews yet

Be the first founder to share your experience with Matthew Hammond. Reviews come from founders whose identity and relationship have been verified.

Write the first review
Reviews of RA Capital Management (0) →

Firm-level reviews are not attributed to Matthew Hammond.

Methodology

This profile carries no tier: tier belongs to the firm and is shown only via the linked firm name — never inherited onto a person.

Credited deals, board seats, Midas years and reputation links are carried per investor in the catalog, each item with the public source it was credited from, linked from the sections above. Fields with no sourced record render their honest null states, and every published field traces to the catalog record listed below. Review dimension scores appear only at three or more reviews.

Corrections with a source: Suggest a correction.

Source record 1

  1. [1]

    DATABASE · GlassVC catalog — Catalog record for Matthew Hammond — provenance: GlassVC catalog

    CATALOG SOURCE FIELD · LAST CHECKED NOV 2026

    ↩ cites: Title · Firm · Type · Bio · Location · Credited deals · Board seats

EVERY FIGURE ON THIS PAGE IS TRACEABLE TO THE CATALOG RECORD ABOVE · LAST CHECKED NOV 2026